Lumosa Therapeutics Co., Ltd. (TPEX:6535)
Taiwan · Delayed Price · Currency is TWD 194.50
+1.50 (0.78%)
Dec 3, 2025, 1:30 PM CST
Lumosa Therapeutics Market Cap
Lumosa Therapeutics has a market cap or net worth of 32.51 billion as of December 3, 2025. Its market cap has decreased by -43.19% in one year.
Market Cap
32.51B
Enterprise Value
31.69B
Revenue
42.59M
Ranking
n/a
PE Ratio
n/a
Stock Price
194.50
Market Cap Chart
Since July 16, 2015, Lumosa Therapeutics's market cap has increased from 4.29B to 32.51B, an increase of 657.02%. That is a compound annual growth rate of 21.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 2, 2025 | 32.51B | -23.00% |
| Dec 31, 2024 | 42.22B | 274.74% |
| Dec 29, 2023 | 11.27B | 75.37% |
| Dec 30, 2022 | 6.43B | 5.04% |
| Dec 30, 2021 | 6.12B | 17.77% |
| Dec 31, 2020 | 5.19B | 28.50% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 243.49B |
| PharmaEssentia | 190.47B |
| Lotus Pharmaceutical | 82.05B |
| Bora Pharmaceuticals Co., LTD. | 67.80B |
| Lin BioScience | 35.74B |
| Oneness Biotech | 32.72B |
| Center Laboratories | 28.33B |
| Pegavision | 24.22B |